Regeneron Pharmaceuticals, Inc. (REGN)

555.80
11.00 2.00
NASDAQ
Prev Close 567.04
Open 576.00
Day Low/High 555.54 / 576.00
52 Wk Low/High 303.49 / 664.64
Volume 900.11K
Exchange NASDAQ
Shares Outstanding 106.39B
Market Cap 61.98B
P/E Ratio 22.58
Div & Yield N.A. (N.A)

Latest News

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

Jim Cramer: Here's How We're Going to Beat Covid-19

Jim Cramer: Here's How We're Going to Beat Covid-19

Let's talk about what's happening right now to get this thing under control and what it will look like not that long from now.

Jim Cramer: Here's Why the President Is Gambling With Stimulus

Jim Cramer: Here's Why the President Is Gambling With Stimulus

The market is reflecting a triumph of big business over small business, and here's what that means for individual stocks.

Jim Cramer: The President's Behavior Towards Covid-19

Jim Cramer: The President's Behavior Towards Covid-19

I know that Trump's going to blunt our community mask initiative because who needs masks if it isn't a big deal if you are sick?

Trump's Health and the Market, Charts That Matter, Nvidia News, URI Breaks Out

Trump's Health and the Market, Charts That Matter, Nvidia News, URI Breaks Out

Even more important than fiscal support moving forward would be the concept of Covid-19 very soon being effectively treatable for the public.

Real Money Post Industrial Average Outperforms Major Indexes in September

Real Money Post Industrial Average Outperforms Major Indexes in September

The RMPIA rose 13.8% during the quarter, leaving it up just shy of 29% on a year-to-date basis, thanks to performance by CRM, AAPL , NKE and TMO.

Jim Cramer: Does Everyone Out There Perceive That Everything Is a Win?

Jim Cramer: Does Everyone Out There Perceive That Everything Is a Win?

It's remarkable to see such excitement based on totally contradictory theories and themes.

Strength in Regeneron Stock May Not Last Long

Strength in Regeneron Stock May Not Last Long

The charts of REGN could use more than media coverage.

Jim Cramer: What Investors Should Watch and Expect This Week

Jim Cramer: What Investors Should Watch and Expect This Week

This is what's known as a positioning week, and starting Monday you're going to hear a ton of things.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Neither candidate seems to be the enemy of the market -- at least not yet.

Kass: Does a Possible Biden Bump in Equities Lie Ahead?

Kass: Does a Possible Biden Bump in Equities Lie Ahead?

I would not view what appears to be an increasingly likely Democratic victory as a reason to sell stocks.

Will We See a 'Biden Bump' Which May Levitate Stocks Throughout the Balance of the Year?

* The 2016 Presidential election provided the contrary - a Trump win and an advancing stock market * The 2020 Presidential election may provide another contrary - a Biden win and an advancing market * President Trump's path to victory is narrowing *...

Debate Spin, Slowing Recovery, Stimulus Hope, Notes on Regeneron, Disney, Tesla

Debate Spin, Slowing Recovery, Stimulus Hope, Notes on Regeneron, Disney, Tesla

Markets now look to Treasury Secretary Mnuchin and Speaker Pelosi to do something.

Regeneron Cocktail News Good for Happy Hour

"Just one more thing." -- Lt. Columbo The positive Regeneron antibody cocktail news underscores something that I planned to discuss in my opener tomorrow (Is This The Biden Bump?) Specifically, the market has already completed a consolidation phase ...

Sanofi Could Trade Sideways for the Weeks Ahead

Sanofi Could Trade Sideways for the Weeks Ahead

I would consider SNY a hold at this point in time.

Weakening Dollar, Fiscal Relief Gridlock, Walmart+, Trading Albemarle

Weakening Dollar, Fiscal Relief Gridlock, Walmart+, Trading Albemarle

Also, interpreting Tuesday's market, Covid-19 vaccine update, and manufacturing growth.

Here's How I'm Trading XBiotech

Here's How I'm Trading XBiotech

Do these shares get back to the 2020 highs that were reached back in January?

Riding the Rails: I Like the Technical Set-Up at Union Pacific

Riding the Rails: I Like the Technical Set-Up at Union Pacific

Should the economy see some organic growth, this stock can run as high as $220.

The Rally Broadens, Dow Theory, Virus Cocktail, 4 Questions: Market Recon

The Rally Broadens, Dow Theory, Virus Cocktail, 4 Questions: Market Recon

Markets may believe that we are closer to the effective use of vaccines and therapeutics than we know in this battle against Covid-19.

Jim Cramer: No Shinola! Sellers Are Wrong on These 3 Stocks

Jim Cramer: No Shinola! Sellers Are Wrong on These 3 Stocks

Wendy's, Regeneron and Teladoc -- why would you unload them now?

Jim Cramer: Betting Against Science Is a Mug's Game

Jim Cramer: Betting Against Science Is a Mug's Game

The buyers have decided that the researchers and doctors are going to beat the virus, so you better get on board or miss the move.

Regeneron Stock Is Not Cheap - But It Could Be Undervalued

Regeneron Stock Is Not Cheap - But It Could Be Undervalued

Ask yourself: Would you pay a higher multiple for the company that puts together a successful cocktail for Covid-19?

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Jim Cramer: Handicapping the Major Covid-19 Vaccine Makers

Our fate is in the hands of a few dozen companies with a dizzying array of clinical trials, and whoever gets there first is gonna make a fortune.

Charting the Stocks of 3 Covid Treatment Companies

Charting the Stocks of 3 Covid Treatment Companies

Let's take a close look at Gilead Sciences, Regeneron and Eli Lilly.

Jim Cramer: Here's My Sore Thumb Index

Jim Cramer: Here's My Sore Thumb Index

This is how you can tell which camp is winning and which is losing in this time of Covid-contradiction.

Regeneron Raised to Buy at SunTrust

Real Money Post Industrial Average Outperforms, Despite Outbreak

Real Money Post Industrial Average Outperforms, Despite Outbreak

The RMPIA rebounded more than 22% in the June quarter to finish up 7.8% at the 2020 half mark.